References
Venkatesan A, Tunkel AR, Bloch KC et al (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57:1114–1128. https://doi.org/10.1093/cid/cit458
Venkatesan A, Michael BD, Probasco JC et al (2019) Acute encephalitis in immunocompetent adults. Lancet 393:702–716. https://doi.org/10.1016/S0140-6736(18)32526-1
Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840–851. https://doi.org/10.1056/NEJMra1708712
Jeannin-Mayer S, André-Obadia N, Rosenberg S et al (2019) EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol 130:289–296. https://doi.org/10.1016/j.clinph.2018.10.017
Probasco JC, Solnes L, Nalluri A et al (2017) Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 11:e352. https://doi.org/10.1212/NXI.0000000000000352
Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9
Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165. https://doi.org/10.1016/S1474-4422(12)70310-1
Viaccoz A, Desestret V, Ducray F et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563. https://doi.org/10.1212/WNL.0000000000000126
Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772. https://doi.org/10.1016/S1474-4422(18)30244-8
Sonneville R, Demeret S, Klein I et al (2008) Acute disseminated encephalomyelitis in the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Med 34:528–532. https://doi.org/10.1007/s00134-007-0926-2
de Montmollin E, Demeret S, Brulé N et al (2017) Anti-N-methyl-d-aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med 195:491–499. https://doi.org/10.1164/rccm.201603-0507OC
Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12:1–13. https://doi.org/10.3988/jcn.2016.12.1.1
Scheibe F, Prüss H, Mengel AM et al (2017) Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 88:366–370. https://doi.org/10.1212/WNL.0000000000003536
Cohen J, Sotoca J, Gandhi S et al (2019) Autoimmune encephalitis: a costly condition. Neurology. https://doi.org/10.1212/WNL.0000000000006990.10.1212/WNL.0000000000006990
Sonneville R, Mariotte E, Neuville M et al (2016) Early-onset status epilepticus in patients with acute encephalitis. Medicine 95:e4092. https://doi.org/10.1097/MD.0000000000004092
Geis C, Planagumà J, Carreño M et al (2019) Autoimmune seizures and epilepsy. J Clin Investig 129:926–940. https://doi.org/10.1172/JCI125178
de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH et al (2019) Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology 92:e2185–e2196. https://doi.org/10.1212/WNL.0000000000007475
Lejuste F, Thomas L, Picard G et al (2016) Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm 3:e280. https://doi.org/10.1212/NXI.0000000000000280
Schubert J, Brämer D, Huttner HB et al (2019) Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm 6:e514. https://doi.org/10.1212/NXI.0000000000000514
Balu R, McCracken L, Lancaster E et al (2019) A score that predicts 1 year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92:e244–e252. https://doi.org/10.1212/WNL.0000000000006783
Mittal MK, Rabinstein AA, Hocker SE et al (2016) Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 24:240–250. https://doi.org/10.1007/s12028-015-0196-8
Wells E, Hacohen Y, Waldman A et al (2018) Neuroimmune disorders of the central nervous system in children in the molecular era. Nat Rev Neurol 14:433–445. https://doi.org/10.1038/s41582-018-0024-9
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
RS received grants from the French Ministry of Health, the French society of intensive care medicine (SRLF) and the European society of intensive care medicine (ESICM), and lecture fees from Baxter. The other authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sonneville, R., Venkatesan, A. & Honnorat, J. Understanding auto-immune encephalitis in the ICU. Intensive Care Med 45, 1795–1798 (2019). https://doi.org/10.1007/s00134-019-05773-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-019-05773-0